Clinical Trial: A Study of [14C]-LY4065967 in Healthy Participants

U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07039045) titled 'A Study of [14C]-LY4065967 in Healthy Participants' on June 19.

Brief Summary: The purpose of this study is to investigate the absorption, metabolism, excretion, and bioavailability of LY4065967 in healthy male participants. This is a 2-part study. The study will last about 58 days for participants in Part 1 and about 60 days for participants in Part 2.

Study Start Date: June, 2025

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: LY4065967

Oral dose

RADIATION: [14C]-LY4065967 Oral

Oral dose

RADIATION: [14C]-LY4065967 IV

IV dose

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Eli Lilly and Company

Discl...